Icahn v. Ackman

Rangeley Capital's Portfolio Managers, Chris DeMuth and Andrew Walker, discuss the ongoing Bill Ackman / Carl Icahn feud over Herbalife (HLF). Then, they discuss the rational behind the massive premiums Allergan (AGN) paid for Tobira (TBRA) and Vitae (VTAE).